Log In
Print
BCIQ
Print
Print this Print this
 

Cortiment MMX, Uceris (Budesonide MMX)

  Manage Alerts
Collapse Summary General Information
Company Cosmo Pharmaceuticals S.p.A.
DescriptionBudesonide delivered using MMX multi-matrix system technology
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat micoscopic colitis; Treat pediatric ulcerative colitis (UC); Treat ulcerative colitis (UC)
Regulatory Designation

Partner

Ferring Pharmaceuticals A/S


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today